vs
MIMEDX GROUP, INC.（MDXG）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
MIMEDX GROUP, INC.的季度营收约是Resolute Holdings Management, Inc.的1.0倍（$118.1M vs $117.7M），MIMEDX GROUP, INC.净利率更高（12.9% vs -1.5%，领先14.3%）
MiMedx是一家总部位于美国佐治亚州玛丽埃塔的生物医疗企业，成立于2008年。该企业以胎盘、羊膜囊、脐带等分娩组织为原料，开发可用于植皮手术的医用真皮产品，在生物再生医疗领域开展业务。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
MDXG vs RHLD — 直观对比
营收规模更大
MDXG
是对方的1.0倍
$117.7M
净利率更高
MDXG
高出14.3%
-1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $118.1M | $117.7M |
| 净利润 | $15.2M | $-1.7M |
| 毛利率 | 83.9% | 55.7% |
| 营业利润率 | 17.8% | 30.2% |
| 净利率 | 12.9% | -1.5% |
| 营收同比 | 27.1% | — |
| 净利润同比 | 104.2% | — |
| 每股收益（稀释后） | $0.10 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDXGRHLD
| Q4 25 | $118.1M | $117.7M | ||
| Q3 25 | $113.7M | $120.9M | ||
| Q2 25 | $98.6M | $119.6M | ||
| Q1 25 | $88.2M | $103.9M | ||
| Q4 24 | $92.9M | — | ||
| Q3 24 | $84.1M | — | ||
| Q2 24 | $87.2M | — | ||
| Q1 24 | $84.7M | — |
净利润MDXGRHLD
| Q4 25 | $15.2M | $-1.7M | ||
| Q3 25 | $16.7M | $-231.0K | ||
| Q2 25 | $9.6M | $-611.0K | ||
| Q1 25 | $7.0M | $-3.4M | ||
| Q4 24 | $7.4M | — | ||
| Q3 24 | $8.1M | — | ||
| Q2 24 | $17.6M | — | ||
| Q1 24 | $9.3M | — |
毛利率MDXGRHLD
| Q4 25 | 83.9% | 55.7% | ||
| Q3 25 | 83.5% | 59.0% | ||
| Q2 25 | 81.1% | 57.5% | ||
| Q1 25 | 81.2% | 52.5% | ||
| Q4 24 | 81.8% | — | ||
| Q3 24 | 81.8% | — | ||
| Q2 24 | 83.0% | — | ||
| Q1 24 | 84.7% | — |
营业利润率MDXGRHLD
| Q4 25 | 17.8% | 30.2% | ||
| Q3 25 | 19.5% | 34.3% | ||
| Q2 25 | 12.5% | 34.0% | ||
| Q1 25 | 9.4% | 24.7% | ||
| Q4 24 | 11.9% | — | ||
| Q3 24 | 13.3% | — | ||
| Q2 24 | 26.9% | — | ||
| Q1 24 | 15.6% | — |
净利率MDXGRHLD
| Q4 25 | 12.9% | -1.5% | ||
| Q3 25 | 14.7% | -0.2% | ||
| Q2 25 | 9.8% | -0.5% | ||
| Q1 25 | 8.0% | -3.2% | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 9.6% | — | ||
| Q2 24 | 20.2% | — | ||
| Q1 24 | 10.9% | — |
每股收益（稀释后）MDXGRHLD
| Q4 25 | $0.10 | $-0.20 | ||
| Q3 25 | $0.11 | $-0.03 | ||
| Q2 25 | $0.06 | $-0.07 | ||
| Q1 25 | $0.05 | $-0.39 | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.05 | — | ||
| Q2 24 | $0.12 | — | ||
| Q1 24 | $0.06 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $166.1M | $205.5M |
| 总债务越低越好 | $18.0M | $169.8M |
| 股东权益账面价值 | $256.5M | $6.5M |
| 总资产 | $342.7M | $333.4M |
| 负债/权益比越低杠杆越低 | 0.07× | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资MDXGRHLD
| Q4 25 | $166.1M | $205.5M | ||
| Q3 25 | $142.1M | $148.0M | ||
| Q2 25 | $118.9M | $99.9M | ||
| Q1 25 | $106.4M | $71.0M | ||
| Q4 24 | $104.4M | — | ||
| Q3 24 | $88.8M | — | ||
| Q2 24 | $69.0M | — | ||
| Q1 24 | $48.5M | — |
总债务MDXGRHLD
| Q4 25 | $18.0M | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | $19.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MDXGRHLD
| Q4 25 | $256.5M | $6.5M | ||
| Q3 25 | $238.9M | $10.8M | ||
| Q2 25 | $216.6M | $9.6M | ||
| Q1 25 | $202.8M | $8.9M | ||
| Q4 24 | $193.1M | — | ||
| Q3 24 | $181.0M | — | ||
| Q2 24 | $168.0M | — | ||
| Q1 24 | $155.7M | — |
总资产MDXGRHLD
| Q4 25 | $342.7M | $333.4M | ||
| Q3 25 | $319.0M | $293.2M | ||
| Q2 25 | $291.1M | $253.3M | ||
| Q1 25 | $270.4M | $214.3M | ||
| Q4 24 | $263.9M | — | ||
| Q3 24 | $243.9M | — | ||
| Q2 24 | $230.2M | — | ||
| Q1 24 | $221.7M | — |
负债/权益比MDXGRHLD
| Q4 25 | 0.07× | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.0M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | — | $189.2M |
| 自由现金流率自由现金流/营收 | — | 160.8% |
| 资本支出强度资本支出/营收 | — | 5.8% |
| 现金转化率经营现金流/净利润 | 1.64× | — |
| 过去12个月自由现金流最近4个季度 | — | $313.2M |
8季度趋势，按日历期对齐
经营现金流MDXGRHLD
| Q4 25 | $25.0M | $196.1M | ||
| Q3 25 | $29.3M | $59.6M | ||
| Q2 25 | $14.4M | $48.9M | ||
| Q1 25 | $5.3M | $18.4M | ||
| Q4 24 | $18.8M | — | ||
| Q3 24 | $19.6M | — | ||
| Q2 24 | $21.8M | — | ||
| Q1 24 | $6.0M | — |
自由现金流MDXGRHLD
| Q4 25 | — | $189.2M | ||
| Q3 25 | — | $58.6M | ||
| Q2 25 | — | $47.5M | ||
| Q1 25 | — | $17.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率MDXGRHLD
| Q4 25 | — | 160.8% | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 17.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度MDXGRHLD
| Q4 25 | — | 5.8% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率MDXGRHLD
| Q4 25 | 1.64× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.50× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 2.53× | — | ||
| Q3 24 | 2.42× | — | ||
| Q2 24 | 1.24× | — | ||
| Q1 24 | 0.65× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDXG
| Wound | $78.7M | 67% |
| Surgical | $39.4M | 33% |
RHLD
暂无分部数据
